Skip Navigation

Risk-Stratified Randomized Phase III Testing of Blinatumomab IND117467, NSC765986 in First Relapse of Childhood B-Lymphoblastic Leukemia B-ALL

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT02101853

Study #:
CMH - AALL1331

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02101853

View Complete Trial Details & Eligibility at ClinicalTrials.gov